RTCA
Basic information
Region (hg38): 1:100266216-100292769
Previous symbols: [ "RTCD1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RTCA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 25 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 2 | 1 |
Variants in RTCA
This is a list of pathogenic ClinVar variants found in the RTCA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-100266406-A-G | not specified | Likely benign (May 13, 2022) | ||
1-100266584-G-A | not specified | Uncertain significance (Jun 16, 2023) | ||
1-100266617-G-T | not specified | Uncertain significance (Feb 27, 2023) | ||
1-100268164-A-C | not specified | Uncertain significance (Dec 03, 2021) | ||
1-100268257-C-G | not specified | Uncertain significance (Jan 23, 2023) | ||
1-100268272-C-A | not specified | Uncertain significance (Nov 12, 2021) | ||
1-100270579-G-T | not specified | Uncertain significance (Nov 10, 2022) | ||
1-100270580-T-A | not specified | Uncertain significance (Feb 28, 2023) | ||
1-100270653-G-A | not specified | Uncertain significance (Apr 22, 2022) | ||
1-100273401-A-G | not specified | Uncertain significance (Jun 26, 2023) | ||
1-100274841-G-C | not specified | Uncertain significance (May 05, 2022) | ||
1-100274856-T-C | not specified | Uncertain significance (May 26, 2023) | ||
1-100274862-G-A | not specified | Uncertain significance (Jun 22, 2021) | ||
1-100274907-G-T | not specified | Uncertain significance (Mar 20, 2023) | ||
1-100274913-G-A | not specified | Uncertain significance (Dec 14, 2021) | ||
1-100274924-A-G | not specified | Uncertain significance (Mar 13, 2023) | ||
1-100274929-T-C | Benign (Jun 20, 2018) | |||
1-100274951-G-A | not specified | Uncertain significance (Sep 27, 2021) | ||
1-100275602-G-A | not specified | Uncertain significance (Jun 13, 2024) | ||
1-100275612-T-C | not specified | Uncertain significance (May 15, 2024) | ||
1-100275720-T-G | not specified | Uncertain significance (Dec 09, 2023) | ||
1-100277266-C-A | not specified | Uncertain significance (Jan 09, 2023) | ||
1-100285236-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
1-100285288-A-G | not specified | Uncertain significance (Oct 12, 2021) | ||
1-100285317-G-C | not specified | Uncertain significance (Aug 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RTCA | protein_coding | protein_coding | ENST00000260563 | 12 | 26563 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.09e-9 | 0.512 | 125711 | 0 | 36 | 125747 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.303 | 195 | 207 | 0.941 | 0.0000104 | 2445 |
Missense in Polyphen | 41 | 49.911 | 0.82146 | 557 | ||
Synonymous | -0.317 | 77 | 73.5 | 1.05 | 0.00000393 | 738 |
Loss of Function | 1.10 | 16 | 21.5 | 0.744 | 0.00000113 | 266 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000448 | 0.000448 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000116 | 0.000114 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000197 | 0.000196 |
Other | 0.000166 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the conversion of 3'-phosphate to a 2',3'- cyclic phosphodiester at the end of RNA. The mechanism of action of the enzyme occurs in 3 steps: (A) adenylation of the enzyme by ATP; (B) transfer of adenylate to an RNA-N3'P to produce RNA- N3'PP5'A; (C) and attack of the adjacent 2'-hydroxyl on the 3'- phosphorus in the diester linkage to produce the cyclic end product. The biological role of this enzyme is unknown but it is likely to function in some aspects of cellular RNA processing.;
Recessive Scores
- pRec
- 0.269
Intolerance Scores
- loftool
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 75.29
Haploinsufficiency Scores
- pHI
- 0.161
- hipred
- N
- hipred_score
- 0.397
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rtca
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- RNA processing
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA binding;RNA-3'-phosphate cyclase activity;ATP binding